Logo
Apparel & Fashion

Description

Flunarizine bulk active pharmaceutical ingredient (API) represents a high-quality calcium channel blocker manufactured in FDA-approved facilities with comprehensive pharmacopeial compliance. Available in IP, BP, EP, USP, and injectable grades, this API meets the stringent requirements of global pharmaceutical manufacturers. With manufacturing expertise dating back to 1971, we ensure consistent batch-to-batch uniformity, reliable supply chain management, and complete regulatory documentation including certificates of analysis. The product demonstrates excellent stability profiles and high bioavailability, making it ideal for various formulation technologies and therapeutic applications in neurological and cardiovascular medicine.

This API finds extensive application in pharmaceutical companies specializing in neurological and cardiovascular therapeutics. It serves as the critical active component in medications designed for migraine prophylaxis, vestibular disorder management, and cere...
Flunarizine bulk active pharmaceutical ingredient (API) represents a high-quality calcium channel blocker manufactured in FDA-approved facilities with comprehensive pharmacopeial compliance. Available in IP, BP, EP, USP, and injectable grades, this API meets the stringent requirements of global pharmaceutical manufacturers. With manufacturing expertise dating back to 1971, we ensure consistent batch-to-batch uniformity, reliable supply chain management, and complete regulatory documentation including certificates of analysis. The product demonstrates excellent stability profiles and high bioavailability, making it ideal for various formulation technologies and therapeutic applications in neurological and cardiovascular medicine.

This API finds extensive application in pharmaceutical companies specializing in neurological and cardiovascular therapeutics. It serves as the critical active component in medications designed for migraine prophylaxis, vestibular disorder management, and cerebrovascular improvement. The manufacturing sector values our Flunarizine API for its adherence to international quality standards including FDA approvals, WHO-GMP compliance, and ISO certifications. Primary applications include solid dosage forms such as tablets and capsules, with growing utilization in extended-release formulations and combination therapies that enhance patient compliance and treatment effectiveness across diverse healthcare markets.

Businesses selecting our Flunarizine API benefit from five decades of manufacturing excellence and supply reliability. Our quality assurance protocols incorporate rigorous testing for impurities, stability verification, and dissolution profile analysis to guarantee final product safety and efficacy. We provide comprehensive regulatory support and documentation that simplifies compliance processes for clients targeting regulated markets. This partnership approach offers competitive advantages through dependable API sourcing, technical expertise, and consistent product quality that pharmaceutical manufacturers can trust for their critical formulations.

Key Features:
- Multiple pharmacopeial grade options including IP, BP, EP, USP, and injectable
- Manufactured in FDA-approved facility with WHO-GMP and ISO certifications
- High purity levels typically exceeding 99.5% with comprehensive COA
- Excellent stability maintained under standard storage conditions
- Consistent batch-to-batch uniformity ensuring formulation reliability

Benefits:
- Global regulatory compliance simplifies market entry and approvals
- Reliable supply chain with consistent quality since 1971
- Enhanced formulation flexibility across various dosage forms
- Reduced development time with proven stability and compatibility
- Comprehensive technical and regulatory support provided

Specifications

Additional Information
Country of OriginIndia

Application

Flunarizine API serves as a selective calcium channel blocker primarily used in neurological and cardiovascular medications. It effectively prevents migraine attacks and manages vestibular disorders by stabilizing neuronal membranes and improving cerebral blood flow. The API's consistent quality makes it suitable for long-term prophylactic treatments with minimal side effects, meeting diverse therapeutic needs across patient populations. Pharmaceutical manufacturers utilize this high-purity API in formulating tablets, capsules, and injectable medications for global markets. It enables production of drugs that reduce migraine frequency and severity while effectively treating balance disorders like vertigo. Compliance with international pharmacopeial standards ensures compatibility with various drug delivery systems and regulatory requirements across different regions. - Manufacturing prescription medications for migraine prevention and frequency reduction - Producing vertigo management drugs for vestibular disorder treatment - Formulating neurological therapeutics for cerebrovascular conditions - Developing adjuvant therapies for epilepsy and seizure disorders - Creating specialized medications for geriatric cerebral circulation improvement

Trade Details

Available StockIn Stock
Sample AvailabilityNo

Payment Terms

Payment Terms
  • Custom Terms (manual entry)

Company Profile

A. S. Joshi & Company, Maharashtra
TruBasic
IndiaMaharashtra, India
Distributor / Wholesaler•Importer / Exporter
Factory Details
Factory SizeBelow 1000 sqm
Annual Production Capacity0

Flunarizine API Bulk IP BP EP USP Injectable FDA Approved

Flunarizine API bulk IP BP EP USP injectable FDA approved pharmaceutical grade for migraine prevention and vertigo treatment from trusted manufacturer since 1971 with reliable global supply.

Min. Order Quantity: 1 unit

Shipping

Shipping fee and delivery date to be negotiated. Contact supplier now for more details.

A. S. Joshi & Company
TruBasic
IndiaMaharashtra, India
Distributor / Wholesaler

More Products From Supplier